2'-Hydroxy ceramide in membrane homeostasis and cell signaling

Advances in Biological Regulation

Volumn 54, Issue 1, 2014, Pages 223-230

  Kota, Venkatesh ^a   Hama, Hiroko ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; MIXED FUNCTION OXIDASE;

ANIMAL; CELL MEMBRANE; CHEMISTRY; GENETICS; HOMEOSTASIS; HUMAN; METABOLISM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL MEMBRANE; CERAMIDES; HOMEOSTASIS; HUMANS; MIXED FUNCTION OXYGENASES; SIGNAL TRANSDUCTION;

EID: 84893350157     PISSN: 22124926     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.jbior.2013.09.012     Document Type: Review

References (49)

1. Alderson N.L., Hama H. Fatty acid 2-hydroxylase regulates cAMP-induced cell cycle exit in D6P2T Schwannoma cells. JLipid Res 2009, 50:1203-1208.
2. Alderson N.L., Rembiesa B.M., Walla M.D., Bielawska A., Bielawski J., Hama H. The human FA2H gene encodes a fatty acid 2-hydroxylase. JBiol Chem 2004, 279:48562-48568.
3. Atanasoski S., Boller D., De Ventura L., Koegel H., Boentert M., Young P., et al. Cell cycle inhibitors p21 and p16 are required for the regulation of Schwann cell proliferation. Glia 2006, 53:147-157.
4. Barcelo-Coblijn G., Martin M.L., De Almeida R.F., Noguera-Salva M.A., Marcilla-Etxenike A., Guardiola-Serrano F., et al. Sphingomyelin and sphingomyelin synthase (SMS) in the malignant transformation of glioma cells and in 2-hydroxyoleic acid therapy. Proc Natl Acad Sci U S A 2011, 108:19569-19574.
5. Boggs J.M., Koshy K.M., Rangaraj G. Influence of structural modifications on the phase behavior of semi- synthetic cerebroside sulfate. BiochimBiophysActa 1988, 938:361-372.
6. Breiden B., Sandhoff K. The role of sphingolipid metabolism in cutaneous permeability barrier formation. Biochim Biophys Acta 2013, (Aug 15. (Epub ahead of print)).
7. Cao L., Huang X.J., Chen C.J., Chen S.D. Arare family with hereditary spastic paraplegia Type 35 due to novel FA2H mutations: a case report with literature review. JNeurol Sci 2013, 329:1-5.
8. Clark R., Stewart M., Miskimins W.K., Miskimins R. Involvement of MAP kinase in the cyclic AMP induction of myelin basic protein gene expression. Int J Dev Neurosci 1998, 16:323-331.
9. Dan P., Edvardson S., Bielawski J., Hama H., Saada A. 2-Hydroxylated sphingomyelin profiles in cells from patients with mutated fatty acid 2-hydroxylase. Lipids Health Dis 2011, 10:84.
10. Deuel H.J. Chemistry of the phosphatides and cerebrosides. The lipids, their chemistry and biochemistry 1951, 405-496. Interscience Publishers, New York. H.J. Deuel (Ed.).
11. Dick K.J., Eckhardt M., Paisan-Ruiz C., Alshehhi A.A., Proukakis C., Sibtain N.A., et al. Mutation of FA2H underlies a complicated form of hereditary spastic paraplegia (SPG35). Hum Mutat 2010, 31:E1251-1260.
12. Donkervoort S., Dastgir J., Hu Y., Zein W., Marks H., Blackstone C., et al. Phenotypic variability of a likely FA2H founder mutation in a family with complicated hereditary spastic paraplegia. Clin Genet 2013, [Epub ahead of print].
13. Edvardson S., Hama H., Shaag A., Gomori J.M., Berger I., Soffer D., et al. Mutations in the fatty acid 2-hydroxylase gene are associated with leukodystrophy with spastic paraparesis and dystonia. Am J Hum Genet 2008, 83:643-648.
14. Friessen A.J., Miskimins W.K., Miskimins R. Cyclin-dependent kinase inhibitor p27kip1 is expressed at high levels in cells that express a myelinating phenotype. JNeurosci Res 1997, 50:373-382.
15. Garone C., Pippucci T., Cordelli D.M., Zuntini R., Castegnaro G., Marconi C., et al. FA2H-related disorders: a novel c.270+3A>T splice-site mutation leads to a complex neurodegenerative phenotype. Dev Med Child Neurol 2011, 53:958-961.
16. Guo L., Zhang X., Zhou D., Okunade A.L., Su X. Stereospecificity of fatty acid 2-hydroxylase and differential functions of 2-hydroxy fatty acid enantiomers. JLipid Res 2012, 53:1327-1335.
17. Guo L., Zhou D., Pryse K.M., Okunade A.L., Su X. Fatty acid 2-hydroxylase mediates diffusional mobility of raft-associated lipids, GLUT4 level, and lipogenesis in 3T3-L1 adipocytes. JBiol Chem 2010, 285:25438-25447.
18. Hama H. Fatty acid 2-Hydroxylation in mammalian sphingolipid biology. Biochim Biophys Acta 2010, 1801:405-414.
19. Jenske R., Vetter W. Enantioselective analysis of 2- and 3-hydroxy fatty acids in food samples. JAgric Food Chem 2008, 56:11578-11583.
20. Ji L., Zhang G., Uematsu S., Akahori Y., Hirabayashi Y. Induction of apoptotic DNA fragmentation and cell death by natural ceramide. FEBS Lett 1995, 358:211-214.
21. Karlsson K., Nilsson K., Samuelsson B.E., Steen G.O. The presence of hydroxy fatty acids in sphingomyelins of bovine rennet stomach. Biochim Biophys Acta 1969, 176:660-663.
22. Klenk E. Über die Cerebronsäure. (9. Mitteilung über Cerebroside.). Hoppe Seylers ZPhysiolChem 1928, 179:312-319.
23. Kota V., Dhople V.M., Fullbright G., Smythe N.M., Szulc Z.M., Bielawska A., et al. 2 -Hydroxy C16-ceramide induces apoptosis-associated proteomic changes in C6 glioma cells. JProteome Res 2013, 12:4366-4375.
24. Kruer M.C., Paisan-Ruiz C., Boddaert N., Yoon M.Y., Hama H., Gregory A., et al. Defective FA2H leads to a novel form of neurodegeneration with brain iron accumulation (NBIA). Ann Neurol 2010, 68:611-618.
25. Kyogashima M., Tadano-Aritomi K., Aoyama T., Yusa A., Goto Y., Tamiya-Koizumi K., et al. Chemical and apoptotic properties of hydroxy-ceramides containing long-chain bases with unusual alkyl chain lengths. JBiochem 2008, 144:95-106.
26. Lofgren H., Pascher I. Molecular arrangements of sphingolipids. The monolayer behavior of ceramides. ChemPhysLipids 1977, 20:273-284.
27. Madison K.C. Barrier function of the skin: "la raison d'etre" of the epidermis. JInvest Dermatol 2003, 121:231-241.
28. Maldonado E.N., Alderson N.L., Monje P.V., Wood P.M., Hama H. FA2H is responsible for the formation of 2-hydroxy galactolipids in peripheral nervous system myelin. JLipid Res 2008, 49:153-161.
29. Marcilla-Etxenike A., Martin M.L., Noguera-Salva M.A., Garcia-Verdugo J.M., Soriano-Navarro M., Dey I., et al. 2-Hydroxyoleic acid induces ER stress and autophagy in various human glioma cell lines. PLoS One 2012, 7:e48235.
30. Martin M.L., Barcelo-Coblijn G., De Almeida R.F., Noguera-Salva M.A., Teres S., Higuera M., et al. The role of membrane fatty acid remodeling in the antitumor mechanism of action of 2-hydroxyoleic acid. Biochim Biophys Acta 2013, 1828:1405-1413.
31. Martin M.L., Liebisch G., Lehneis S., Schmitz G., Alonso-Sande M., Bestard-Escalas J., et al. Sustained activation of sphingomyelin synthase by 2-hydroxyoleic acid induces sphingolipidosis in tumor cells. JLipid Res 2013, 54:1457-1465.
32. Mislow K., Bleicher S. The configuration of cerebronic acid. JAmChemSoc 1954, 76:2825-2826.
33. Mizutani Y., Kihara A., Chiba H., Tojo H., Igarashi Y. 2-Hydroxy-ceramide synthesis by ceramide synthase family: enzymatic basis for the preference of FA chain length. JLipid Res 2008, 49:2356-2364.
34. Pascher I. Molecular arrangements in sphingolipids. Conformation and hydrogen bonding of ceramide and their implication on membrane stability and permeability. BiochimBiophysActa 1976, 455:433-451.
35. Pascher I., Sundell S. Molecular arrangements in sphingolipids. The crystal structure of cerebroside. ChemPhysLipids 1977, 20:175-191.
36. Pierson T.M., Simeonov D.R., Sincan M., Adams D.A., Markello T., Golas G., et al. Exome sequencing and SNP analysis detect novel compound heterozygosity in fatty acid hydroxylase-associated neurodegeneration. Eur J Hum Genet 2012, 20:476-479.
37. Potter K.A., Kern M.J., Fullbright G., Bielawski J., Scherer S.S., Yum S.W., et al. Central nervous system dysfunction in a mouse model of FA2H deficiency. Glia 2011, 59:1009-1021.
38. Rabionet M., Gorgas K., Sandhoff R. Ceramide synthesis in the epidermis. Biochim Biophys Acta 2013, (Aug 27. (Epub ahead of print)).
39. Robson K.J., Stewart M.E., Michelsen S., Lazo N.D., Downing D.T. 6-Hydroxy-4-sphingenine in human epidermal ceramides. JLipid Res 1994, 35:2060-2068.
40. Rupps R., Hukin J., Balicki M., Mercimek-Mahmutoglu S., Rolfs A., Dias C. Novel mutations in FA2H-associated neurodegeneration: an under recognized condition?. JChild Neurol 2012, (Sep 10. (Epub ahead of print)).
41. Stewart M.E., Downing D.T. Anew 6-hydroxy-4-sphingenine-containing ceramide in human skin. JLipid Res 1999, 40:1434-1439.
42. Stewart R.J., Boggs J.M. Acarbohydrate-carbohydrate interaction between galactosylceramide-containing liposomes and cerebroside sulfate-containing liposomes: dependence on the glycolipid ceramide composition. Biochemistry 1993, 32:10666-10674.
43. Szulc Z.M., Bai A., Bielawski J., Mayroo N., Miller D.E., Gracz H., et al. Synthesis, NMR characterization and divergent biological actions of 2'-hydroxy-ceramide/dihydroceramide stereoisomers in MCF7 cells. BioorgMedChem 2010, 18:7565-7579.
44. Teres S., Llado V., Higuera M., Barcelo-Coblijn G., Martin M.L., Noguera-Salva M.A., et al. 2-Hydroxyoleate, a nontoxic membrane binding anticancer drug, induces glioma cell differentiation and autophagy. Proc Natl Acad Sci U S A 2012, 109:8489-8494.
45. Thudicum J.L.W. Atreatise on the chemical composition of the brain 1884, Bailliere, Tindall, and Cox, London.
46. Tonelli A., D'angelo M.G., Arrigoni F., Brighina E., Arnoldi A., Citterio A., et al. Atypical adult onset complicated spastic paraparesis with thin corpus callosum in two patients carrying a novel FA2H mutation. Eur J Neurol 2012, 19:e127-129.
47. Uchida Y., Hama H., Alderson N.L., Douangpanya S., Wang Y., Crumrine D.A., et al. Fatty acid 2-hydroxylase, encoded by FA2H, accounts for differentiation-associated increase in 2-OH ceramides during keratinocyte differentiation. JBiol Chem 2007, 282:13211-13219.
48. Zanetti S.R., De Los Angeles Monclus M., Rensetti D.E., Fornes M.W., Aveldano M.I. Ceramides with 2-hydroxylated, very long-chain polyenoic fatty acids in rodents: from testis to fertilization-competent spermatozoa. Biochimie 2010, 92:1778-1786.
49. Zoller I., Meixner M., Hartmann D., Bussow H., Meyer R., Gieselmann V., et al. Absence of 2-hydroxylated sphingolipids is compatible with normal neural development but causes late-onset axon and myelin sheath degeneration. JNeurosci 2008, 28:9741-9754.